文献速递脑血管病

胰岛素抵抗与非糖尿病缺血性卒中患者预后:ACROSS-China研究

Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke: The ACROSS-China Study (Abnormal Glucose Regulation in Patients With Acute Stroke Across China).
PubMed 文献 · Stroke · 2017-02-24

本研究基于ACROSS-China登记,纳入1245例无糖尿病史的急性缺血性卒中患者,以HOMA-IR最高四分位定义胰岛素抵抗,分析其与1年预后的关联。结果显示胰岛素抵抗与死亡、卒中复发和不良功能结局风险升高相关,但与依赖无显著关联。

要点

  • 非糖尿病急性缺血性卒中患者中,HOMA-IR最高四分位与1年死亡风险升高相关。
  • 胰岛素抵抗与卒中复发和不良功能结局风险升高相关。
  • 胰岛素抵抗与1年依赖无显著关联。

核心结论

  • 在非糖尿病急性缺血性卒中患者中,胰岛素抵抗与1年死亡、卒中复发和不良结局风险升高相关,但与依赖无显著关联。

研究设计与样本

  • 基于ACROSS-China登记的前瞻性队列研究,纳入1245例无糖尿病史的首次急性缺血性卒中患者。
  • 胰岛素抵抗定义为HOMA-IR指数处于最高四分位(Q4),HOMA-IR按空腹胰岛素(μU/mL)×空腹血糖(mmol/L)/22.5计算。
  • 采用多因素logistic回归或Cox回归评估HOMA-IR与1年预后的关联。

主要发现

  • 研究人群HOMA-IR中位数为1.9(四分位距1.1-3.1)。
  • 胰岛素抵抗组较非抵抗组1年死亡风险升高(校正HR 1.68,95%CI 1.12-2.53,P=0.01)。
  • 胰岛素抵抗组卒中复发风险升高(校正HR 1.57,95%CI 1.12-2.19,P=0.008)。
  • 胰岛素抵抗组不良功能结局风险升高(校正OR 1.42,95%CI 1.03-1.95,P=0.03)。
  • HOMA-IR四分位类别升高与1年死亡、卒中复发和不良结局风险升高呈趋势相关(P for trend分别为0.005、0.005和0.001)。

关键数值与推荐

  • 胰岛素抵抗定义为HOMA-IR指数处于最高四分位(Q4)。
  • 不良功能结局定义为改良Rankin量表评分3-6分。
  • 依赖定义为改良Rankin量表评分3-5分。

临床怎么用

  • 对非糖尿病急性缺血性卒中患者,可计算HOMA-IR以识别胰岛素抵抗,辅助评估1年死亡、复发和不良结局风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Insulin resistance was common in patients with stroke. This study investigated the association between insulin resistance and outcomes in nondiabetic patients with first-ever acute ischemic stroke. METHODS: Patients with ischemic stroke without history of diabetes mellitus in the ACROSS-China registry (Abnormal Glucose Regulation in Patients With Acute Stroke Across China) were included. Insulin resistance was defined as a homeostatis model assessment-insulin resistance (HOMA-IR) index in the top quartile (Q4). HOMA-IR was calculated as fasting insulin (μU/mL)×fasting glucose (mmol/L)/22.5. Multivariable logistic regression or Cox regression was performed to estimate the association between HOMA-IR and 1-year prognosis (mortality, stroke recurrence, poor functional outcome [modified Rankin scale score 3-6], and dependence [modified Rankin scale score 3-5]). RESULTS: Among the 1245 patients with acute ischemic stroke enrolled in this study, the median HOMA-IR was 1.9 (interquartile range, 1.1-3.1). Patients with insulin resistance were associated with a higher mortality risk than those without (adjusted hazard ratio, 1.68; 95% confidence interval, 1.12-2.53; P=0.01), stroke recurrence (adjusted hazard ratio, 1.57, 95% confidence interval, 1.12-2.19; P=0.008), and poor outcome (adjusted odds ratio, 1.42; 95% confidence interval, 1.03-1.95; P=0.03) but not dependence after adjustment for potential confounders. Higher HOMA-IR quartile categories were associated with a higher risk of 1-year death, stroke recurrence, and poor outcome (P for trend =0.005, 0.005, and 0.001, respectively). CONCLUSIONS: Insulin resistance was associated with an increased risk of death, stroke recurrence, and poor outcome but not dependence in nondiabetic patients with acute ischemic stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Jing J, Pan Y, Zhao X, et al. Insulin Resistance and Prognosis of Nondiabetic Patients With Ischemic Stroke: The ACROSS-China Study (Abnormal Glucose Regulation in Patients With Acute Stroke Across China). Stroke. 2017. PMID: 28235959. doi:10.1161/STROKEAHA.116.015613

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。